Article info
Brief report
Patient organisations should also establish databanks on medical complications
Citation
Patient organisations should also establish databanks on medical complications
Publication history
- First published April 1, 2003.
Online issue publication
April 01, 2003
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by the Journal of Medical Ethics
Other content recommended for you
- Financial interests of patient organisations contributing to technology assessment at England’s National Institute for Health and Care Excellence: policy review
- Exposing drug industry funding of UK patient organisations
- Cancer patients’ organisation participation in heath policy decision-making: a snapshot/cluster analysis of the EU-28 countries
- Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence
- Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
- Is the international regulation of medical complicity with torture largely window dressing? The case of Israel and the lessons of a 12-year medical ethical appeal
- Association between medical complications according to continuity of care and medication adherence in patients with hypertension in Korea: a national population-based cohort study
- Patient–physician collaboration in rheumatology: a necessity
- 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
- Reducing the risk of NHS disasters